Clinical Trial Update: A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131] [Phase 3]

View source ↗

Summary

Phase 3 trial comparing atezolizumab combined with carboplatin + paclitaxel or carboplatin + nab-paclitaxel versus carboplatin + nab-paclitaxel in stage IV squa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Squamous Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-11-12